ETRM breaking .60 only 23 mil float
EnteroMedics Inc., a development stage medical device company, focuses on design and development of devices that use neuroblocking technology to treat obesity and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company?s initial product under development is the Maestro System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It focuses on marketing its product to potential referral source clinicians, such as general practitioners, internists, endocrinologists, and nurses. EnteroMedics has collaboration with Mayo Clinic for research and development of devices for vagal blocking therapy to treat obesity. The company formerly known as Beta Medical, Inc. and changed its name to EnteroMedics, Inc. in October 2003. EnteroMedics was founded in 2002 and is headquartered in St. Paul, Minnesota.
News 
Market Data 
Discover 
